A detailed history of Invesco, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Invesco, LLC holds 5,205 shares of LLY stock, worth $3.9 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares
5,205
Previous 5,183 0.42%
Holding current value
$3.9 Million
Previous $4.69 Billion 1.73%
% of portfolio
1.84%
Previous 1.96%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $16,987 - $21,120
22 Added 0.42%
5,205 $4.61 Billion
Q2 2024

Aug 07, 2024

SELL
$724.87 - $909.04 $173,968 - $218,169
-240 Reduced 4.43%
5,183 $4.69 Billion
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $58,627 - $78,435
99 Added 1.86%
5,423 $4.22 Billion
Q4 2023

Jan 30, 2024

SELL
$525.19 - $619.13 $27,835 - $32,813
-53 Reduced 0.99%
5,324 $3.1 Billion
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $183,008 - $252,305
421 Added 8.49%
5,377 $2.89 Billion
Q2 2023

Aug 15, 2023

BUY
$350.74 - $468.98 $1.74 Million - $2.32 Million
4,956 New
4,956 $2.32 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Invesco, LLC Portfolio

Follow Invesco, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invesco, LLC with notifications on news.